GAGordon Gullanyi Ayisi

Gordon Gullanyi Ayisi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gordon Gullanyi Ayisi has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Management of Myelomeningocele Associated with Chiari II Malformation and Hydrocephalus: A Case Report and Literature Review

    by Daniel Encarnación-Santos, Zainab Jallow, Gordon Ayisi, Gennady Chmutin, Egor Chmutin, Marat Zhakenovich Chigibaev, Aleksandr Levov, Adam Romanovish Mainer

    Background: Myelomeningocele remains a relevant and prevalent neurosurgical pathology despite ongoing prevention efforts. Surgical management may be prenatal or postnatal. Associated conditions such as hydrocephalus, Chiari II malformation and tethered cord syndrome require equal attention. Case presentation: We present the case of an infant with myelomeningocele, hydrocephalus, Chiari type II malformation and tethered cord who underwent fetal surgery followed by postnatal surgical repair with simultaneous ventriculoperitoneal shunt implantation. Conclusion: Despite the available options for surgical management of myelomeningocele and its associated conditions, it is crucial to understand that further treatment may be required even after fetal surgery. Management of spina bifida and myelomeningocele requires a multidisciplinary approach and team. Keywords: Spina bifida; Myelomeningocele; Fetal surgery; Chiari II malformation; Hydrocephalus; Tethered cord syndrome.

  • Open Access

    Does the Incidency Duraplasty with Synthetic Dural Graft or Standard Primary Dural Closure reduce the risk of retethering? A comparative analysis of 36 pediatric patients

    by Nazar S. Annanepesov, Daniel Encarnación-Santos, Gordon Gullanyi Ayisi, Gennady Chmutin, Egor Chmutin, Musa Gerald, Aleksandra Andreevna Kuznetsova, Bupe M. Mwela

    Bacground; Spinal lipomas in pediatric patients pose a significant risk of neurological deterioration due to the potential for retethering after surgical excision. This study aims to assess the efficacy of duraplasty in mitigating the risk of retethering following spinal lipoma excision in pediatric patients. We compared outcomes between two groups: one treated with duraplasty using synthetic dura and another with primary dural closure. Methods A retrospective analysis was performed on 36 pediatric patients who underwent spinal lipoma excision between 2019 and 2024. Group 1 (n=15) received duraplasty with synthetic dura, while Group 2 (n=21) underwent primary dural closure. The primary outcome was the incidence of retethering, defined by clinical and radiological criteria, over a follow-up period averaging 2.6 years (range: 2 – 5 years). Results A total of 36 pediatric patients with spinal lipomas were included in this retrospective analysis. The mean age of the study cohort was 9 years and 3 months, ranging from 25 days to 18 years Group 1 demonstrated a significantly lower incidence of retethering (13.3%) compared to Group 2 (38.1%), with a p-value of 0.02. The mean time to retethering was also significantly longer in Group 1 (3.5 years) versus Group 2 (2.1 years), with a p-value of 0.045. Conclusion Duraplasty with synthetic dura may reduce the risk of retethering in pediatric patients undergoing spinal lipoma excision. However, further prospective studies with larger sample sizes are required to validate these findings.